Impact Factor 3.517 | CiteScore 3.60
More on impact ›
The rapidly increasing amount of genome data provides wide opportunities to address new research questions and to translate new knowledge in clinical practice. Currently, most mature areas for clinical applications of genomics include rare disease diagnostics, oncology, infectious diseases, and pharmacogenomics. We expect that the next wave is seen in improving our understanding of chronic diseases that change traditional diagnostic categories. These new disease classifications hopefully result in new, more tailored treatment and prediction options.
Genomic Medicine publishes high-quality research that facilitates the use of genomic information in medicine, including treatment, diagnostics, and prevention. We welcome manuscripts from all disease disciplines, both rare and common disease, and from all steps of the translation process provided that they offer perspective on how the results can be applied to advance and improve health and healthcare.
Examples of areas of interest include:
• Using genomics in patient or treatment stratification
• Using genomics to improve prevention, risk evaluation and early intervention
• Using genomics to monitor disease progression
• Diagnostic applications of genomics
• Genomic strategies to develop treatment modalities
• Policy issues and perspectives regarding the use of genomic data in healthcare
• Communicating genomic information, and the impact of receiving individual genomic risk information
• Methods and strategies for handling genomic data in healthcare-related settings
Indexed in: PubMed, PubMed Central, Scopus, Google Scholar, DOAJ, CrossRef, Chemical Abstracts Service (CAS), EMBASE, AGRICOLA, Semantic Scholar, Ulrich's Periodicals Directory, Science Citation Index Expanded, BIOSIS Citation Index, Biological Abstracts, CLOCKSS, EBSCO, OpenAIRE, Zetoc, Mastermind
Genomic Medicine welcomes submissions of the following article types: Brief Research Report, Case Report, Clinical Trial, Correction, Data Report, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Specialty Grand Challenge, Study Protocol, Systematic Review and Technology and Code.
All manuscripts must be submitted directly to the section Genomic Medicine, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section Genomic Medicine will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Genetics.
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact firstname.lastname@example.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact email@example.com